XML 40 R30.htm IDEA: XBRL DOCUMENT v3.23.2
Stock Options and Restricted Stock Units (Tables)
6 Months Ended
Jun. 30, 2023
Stock Options and Restricted Stock Units  
Schedule of stock-based compensation expense

For the Three Months Ended

For the Six Months Ended

June 30, 

June 30,

    

2023

    

2022

    

2023

    

2022

Direct operating costs

$

62

$

56

$

126

$

107

Selling and administrative expenses

 

957

 

972

 

1,855

 

1,458

Total stock-based compensation

$

1,019

$

1,028

$

1,981

$

1,565

Schedule of weighted average assumptions

For the Six Months Ended June 30, 

    

2023

    

2022

Weighted average fair value of options granted

$

1.79

$

3.10

Risk-free interest rate

3.88

%

1.94%-2.75

%

Expected term (years)

3.0

3.0-6.42

Expected volatility factor

79.95

%

62%-76.48

%

Expected dividends

-

-

Equity Plans  
Stock Options and Restricted Stock Units  
Schedule of stock option activity

 

 

 

Weighted - Average

 

Number of

 

Weighted - Average

 

Remaining Contractual

Aggregate

    

Options

    

Exercise Price

    

Term (years)

    

Intrinsic Value

Outstanding at January 1, 2023

 

6,690,490

$

3.09

 

  

 

  

Granted*

 

25,000

 

3.31

 

  

 

  

Exercised

 

(871,884)

 

2.34

 

  

 

  

Forfeited/Expired

 

(75,766)

 

6.96

 

  

 

  

Outstanding at June 30, 2023

 

5,767,840

$

3.16

 

6.84

$

47,137,674

 

 

 

 

Exercisable at June 30, 2023

 

3,600,261

$

1.91

5.73

$

33,897,858

 

 

 

 

Vested and Expected to Vest at June 30, 2023

 

5,767,840

$

3.16

 

6.84

$

47,137,674

*Granted to a non-employee member of the Company’s advisory board.

    

    

    

Weighted - Average 

    

Number of 

Weighted - Average 

Remaining Contractual 

Aggregate 

Options

Exercise Price

Term (years)

Intrinsic Value

Outstanding at January 1, 2022

5,536,896

$

2.66

  

  

Granted*

 

1,479,558

 

5.21

 

  

 

  

Exercised

 

(146,705)

 

1.17

 

  

 

  

Forfeited/Expired

 

(36,000)

 

5.13

 

  

 

  

Outstanding at June 30, 2022

 

6,833,749

$

3.24

 

7.62

$

13,923,020

Exercisable at June 30, 2022

 

3,578,045

$

1.81

 

6.40

$

11,195,079

Vested and Expected to Vest at June 30, 2022

 

6,833,749

$

3.24

 

7.62

$

13,923,020

*Includes 110,000 stock options granted to a non-employee director of the Company.

2021 Plan

A summary of option activity under the Innodata Inc. 2021 Equity Compensation Plan, as amended and restated effective as of April 11, 2022 (the “2021 Plan”) and changes during each of the six-month periods ended June 30, 2023 and 2022 are presented below.

Weighted - Average

Number of

Weighted - Average

Remaining Contractual

Aggregate

    

Options

    

Exercise Price

    

Term (years)

    

Intrinsic Value

Outstanding at January 1, 2023

 

1,027,500

$

3.46

 

  

 

  

Granted

 

-

 

-

 

  

 

  

Exercised

 

(25,000)

 

6.40

 

  

 

  

Forfeited/Expired

 

(42,000)

 

3.41

 

  

 

  

Outstanding at June 30, 2023

 

960,500

$

3.38

 

9.27

$

7,634,060

Exercisable at June 30, 2023

 

18,750

$

3.39

 

9.21

$

148,875

Vested and Expected to Vest at June 30, 2023

 

960,500

$

3.38

 

9.27

$

7,634,060

   

    

    

Weighted - Average

    

Number of 

Weighted - Average

Remaining Contractual

Aggregate

Options

Exercise Price

Term (years)

Intrinsic Value

Outstanding at January 1, 2022

 

-

$

-

 

  

 

  

Granted*

 

25,000

 

6.40

 

  

 

  

Exercised

 

-

 

-

 

  

 

  

Forfeited/Expired

 

-

 

-

 

  

 

  

Outstanding at June 30, 2022

 

25,000

$

6.40

 

5.00

$

-

Exercisable at June 30, 2022

 

-

$

-

 

  

 

  

Vested and Expected to Vest at June 30, 2022

 

25,000

$

6.40

 

5.00

$

-

*Granted to a non-employee member of the Company’s advisory board.

Restricted Stock Units  
Stock Options and Restricted Stock Units  
Summary of restricted stock under the company's plan

Number of 

 

Weighted-Average

Restricted Stock

Grant Date

    

Units

    

 Fair Value

Unvested at January 1, 2023

700,000

$

5.59

Granted

 

28,804

 

8.29

Vested

 

-

 

-

Forfeited/Expired

 

-

 

-

Unvested at June 30, 2023

 

728,804

$

5.70

For the six months ended June 30, 2023, a total of 28,804 restricted stock units (“RSUs”) were granted under the 2013 Plan. Vesting of the RSUs is contingent on continuous employment by the employee for a 12-month period from the date of grant. Each fully vested RSU represents the right to receive one share of the Company’s common stock or the fair market value of one share of common stock, at the Company’s discretion, and is classified as an equity award. The stock-based compensation expense is recognized on a straight-line basis over a period of 12 months. The fair value of restricted stock units is based on the closing price of the stock at the time of the grant.

    

Number of

    

Weighted-Average

Restricted Stock

Grant Date

Units

Fair Value

Unvested at January 1, 2022

 

-

 

$

-

Granted

 

700,000

5.59

Vested

 

-

 

-

Forfeited/Expired

 

-

 

-

Unvested at June 30, 2022

 

700,000

$

5.59

For the six months ended June 30, 2022, 200,000 performance-based RSUs were granted under the 2013 Plan and 500,000 performance-based RSUs were granted under the 2021 plan. The 700,000 performance based RSUs remain outstanding and unvested at June 30, 2023. Vesting of the performance based RSUs is contingent on the achievement of certain financial performance goals and continuation of employment for a defined period. Each RSU vests pursuant to the vesting schedule found in the respective RSU agreement. The fair value of restricted stock units is estimated on the date of grant using the Binomial option pricing model.